Why the study?
Does subcutaneous G-CSF improve systolic wall thickening in patients with ST-elevation myocardial infarction after primary PCI?
Population
78 patients with ST-elevation myocardial infarction after successful primary percutaneous coronary stent…
Comparison
Subcutaneous granulocyte-colony stimulating… vs Placebo for 6 days
Design
RCT, randomized, double-blind
Follow-up
6 months
Authors
Loading...
Subcutaneous G-CSF adds no benefit over placebo for post-STEMI wall thickening; confirms lack of efficacy on LV recovery.
Does subcutaneous G-CSF improve systolic wall thickening in patients with ST-elevation myocardial infarction after primary PCI?
Subcutaneous G-CSF does not improve left ventricular function or systolic wall thickening beyond placebo in patients with STEMI after primary PCI.
Ripa et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: